review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0009-9120(03)00060-2 |
P698 | PubMed publication ID | 12849862 |
P50 | author | Jean-Claude Forest | Q84761071 |
Jacques Massé | Q58886370 | ||
P2093 | author name string | Bernard Dastugue | |
Vincent Sapin | |||
Yves Giguère | |||
Abdelaziz Kharfi | |||
P2860 | cites work | Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes) | Q78039520 |
Soluble adhesion molecules: marker of pre-eclampsia and intrauterine growth restriction | Q78491793 | ||
Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? | Q24561702 | ||
A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies | Q28239787 | ||
Human cytotrophoblast invasion is up-regulated by epidermal growth factor: evidence that paracrine factors modify this process | Q28245763 | ||
Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor | Q28307227 | ||
Placental development: lessons from mouse mutants | Q29618167 | ||
Reactive oxygen species and proinflammatory cytokine signaling in endothelial cells: effect of selenium supplementation | Q31365465 | ||
Caspase-independent programmed cell death with necrotic morphology | Q33669492 | ||
To be, or not to be, that is the question. Apoptosis in human trophoblast | Q33848686 | ||
Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. | Q33853208 | ||
Preeclampsia: what we know and what we do not know | Q33858363 | ||
Pathogenesis and genetics of pre-eclampsia | Q33934445 | ||
A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2 | Q34144402 | ||
The kidney and hypertension in pregnancy: twenty exciting years | Q34179175 | ||
Genes involved in implantation | Q34361721 | ||
An integrated proposal to explain the epidemic of cardiovascular disease in a developing country. From socioeconomic factors to free radicals | Q34433659 | ||
Use of transgenic mice model for understanding the placentation: towards clinical applications in human obstetrical pathologies? | Q34439148 | ||
Recent Insights into the pathogenesis of pre-eclampsia | Q34682287 | ||
Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models | Q34691722 | ||
Leukemia inhibitory factor and interleukin-11: cytokines with key roles in implantation | Q34973796 | ||
Pathophysiology and maternal biologic markers of preeclampsia | Q35065108 | ||
Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules | Q36361101 | ||
Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. | Q36367185 | ||
Cytokines and endothelial cell biology | Q36565690 | ||
Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast | Q36830490 | ||
Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia | Q37350668 | ||
Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? | Q37366512 | ||
Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia | Q38311843 | ||
Preeclampsia and Related Disorders: Clinical Aspects and Relevance of Endothelin and Nitric Oxide | Q40480472 | ||
Systemic nature of endothelial dysfunction in atherosclerosis | Q40598028 | ||
Etiology and pathogenesis of preeclampsia: current concepts | Q40835002 | ||
HLA-G suppresses proliferation of CD4(+) T-lymphocytes | Q40853928 | ||
Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus | Q40947640 | ||
The expression of human leukocyte antigen-G on trophoblasts abolishes the growth-suppressing effect of interleukin-2 towards them | Q40963259 | ||
Adhesion molecules--Part 1. | Q40980798 | ||
Role of embryonic factors in human implantation | Q41068444 | ||
Tumor necrosis factors: pivotal components of pregnancy? | Q41134851 | ||
Preeclampsia: physiopathology and prospects for early detection | Q41301958 | ||
Placental cytokines and the pathogenesis of preeclampsia | Q41452017 | ||
A repertoire of differentially expressed transcription factors that offers insight into mechanisms of human cytotrophoblast differentiation | Q41684338 | ||
Early stages of trophoblastic invasion of the maternal vascular system during implantation in the macaque and baboon | Q42469220 | ||
Trophoblast cell-mediated modifications to uterine spiral arteries during early gestation in the macaque | Q43723314 | ||
Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction | Q43744794 | ||
Relation between adenosine and T-helper 1/T-helper 2 imbalance in women with preeclampsia | Q44011592 | ||
Localization of transforming growth factor beta2 (TGFbeta2) and its receptors, TbetaRI and TbetaRII, in uteri and blastocysts of the stripe-faced dunnart (Sminthopsis macroura) during gastrulation | Q44118708 | ||
Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia | Q44182258 | ||
Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia | Q44897228 | ||
Peroxide induces vasoconstriction in the human placenta by stimulating thromboxane | Q45090644 | ||
IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion | Q46223856 | ||
Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes | Q46366502 | ||
Regulation of human placental development by oxygen tension | Q46733260 | ||
Trophoblastic invasion and modification of uterine veins during placental development in macaques | Q46941126 | ||
Endothelial dysfunction in preeclampsia | Q47879591 | ||
A prospective longitudinal study of platelet angiotensin II receptors for the prediction of preeclampsia | Q47910741 | ||
Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts | Q47930364 | ||
The role of trophoblast in the physiological change in decidual spiral arteries | Q48565186 | ||
Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. | Q50514586 | ||
Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. | Q50767140 | ||
Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. | Q52237839 | ||
Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. | Q52501980 | ||
Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. | Q53680742 | ||
Activation of the novel prothrombinase, fg12, as a basis for the pregnancy complications spontaneous abortion and pre-eclampsia. | Q53993999 | ||
Novel inflammatory markers of coronary risk: theory versus practice. | Q54332281 | ||
Hypoxia limits differentiation and up-regulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta | Q56440123 | ||
Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia | Q56794536 | ||
Genetic susceptibility to pre-eclampsia and chromosome 7q36 | Q57670394 | ||
Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia | Q58778344 | ||
Death Receptor Fas/Apo-1/CD95 Expressed by Human Placental Cytotrophoblasts Does Not Mediate Apoptosis1 | Q59367405 | ||
Increased placental apoptosis in intrauterine growth restriction | Q59367671 | ||
Placental apoptosis in normal human pregnancy | Q59367743 | ||
Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta | Q61865493 | ||
Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation | Q67535213 | ||
Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants | Q69685000 | ||
Immunohistochemical localization, identification and regulation of the interleukin-1 receptor antagonist in the human endometrium | Q70809297 | ||
Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts | Q71037717 | ||
Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy | Q71413387 | ||
Decay-accelerating factor protects human trophoblast from complement-mediated attack | Q71669589 | ||
Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1 | Q71684241 | ||
Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast | Q72297496 | ||
Immunoreactive tumor necrosis factor-alpha is elevated in maternal plasma but undetected in amniotic fluid in the second trimester | Q72761569 | ||
Interleukin-8 stimulates placental prostacyclin production in preeclampsia | Q73327509 | ||
Expression profiles of interleukin-15 in early and late gestational human placenta and in pre-eclamptic placenta | Q73337192 | ||
Cytotoxic effects of tumour necrosis factor (TNF)-alpha and interferon-gamma on cultured human trophoblast are modulated by fibronectin | Q73934418 | ||
Pathophysiology of pregnancy-induced hypertension | Q74039094 | ||
Placental apoptosis in preeclampsia | Q74047219 | ||
Contemporary concepts of the pathogenesis and management of preeclampsia | Q74331806 | ||
Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia | Q74455336 | ||
Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats | Q74518978 | ||
Apoptotic and proliferative activities in first trimester placentae | Q77297152 | ||
Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease | Q77384771 | ||
Circulating levels of immunoreactive cytokines in women with preeclampsia | Q77384781 | ||
Cytokine expression in peripheral blood lymphocytes indicates a switch to T(HELPER) cells in patients with preeclampsia | Q77626180 | ||
Interaction of interstitial trophoblast with placental bed capillaries and venules of normotensive and pre-eclamptic pregnancies | Q77707578 | ||
Increased levels of macrophage colony-stimulating factor in the placenta and blood in preeclampsia | Q77741981 | ||
Stress in pregnancy: a new Wistar rat model for human preeclampsia | Q77794705 | ||
Immunoendocrinology of preterm labor: the link between corticotropin-releasing hormone and inflammation | Q77893231 | ||
P433 | issue | 5 | |
P1104 | number of pages | 9 | |
P304 | page(s) | 323-331 | |
P577 | publication date | 2003-07-01 | |
P1433 | published in | Clinical Biochemistry | Q5133749 |
P1476 | title | Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines | |
P478 | volume | 36 |
Q44209823 | A 12-year cohort study on adverse pregnancy outcomes in Eastern Townships of Canada: impact of endometriosis |
Q33963982 | A synthetic thiourea-based tripodal receptor that impairs the function of human first trimester cytotrophoblast cells |
Q51857820 | Ablation of Tpbpa-positive trophoblast precursors leads to defects in maternal spiral artery remodeling in the mouse placenta. |
Q35738082 | Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia |
Q38742589 | Cinobufotalin impedes Sw.71 cytotrophoblast cell line function via cell cycle arrest and apoptotic signaling |
Q47688833 | Continued Investigation Into 17-OHPC: Results From the Preclinical RUPP Rat Model of Preeclampsia |
Q28218814 | Control of human trophoblast function |
Q26830707 | Cytokines as key players in the pathophysiology of preeclampsia |
Q47734340 | Cytokines, hypoxia, and preeclampsia |
Q89801374 | Differential DNA Methylation in Placenta Associated With Maternal Blood Pressure During Pregnancy |
Q38747396 | Effect of Cytokines on the Formation Tube-Like Structures by Endothelial Cells in the Presence of Trophoblast Cells. |
Q38909814 | Effects of vitamin C, vitamin E, and molecular hydrogen on the placental function in trophoblast cells |
Q51747957 | Elevated serum levels of interleukin-15, interleukin-16, and human chorionic gonadotropin in women with preeclampsia. |
Q39988758 | Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function |
Q37139722 | Identifying immune mechanisms mediating the hypertension during preeclampsia |
Q64227446 | Immune imbalance is associated with the development of preeclampsia |
Q46337204 | Impaired placental neovascularization in mice with pregnancy-associated hypertension |
Q53033049 | Maternal circulating interferon-gamma and interleukin-6 as biomarkers of Th1/Th2 immune status throughout pregnancy. |
Q37196036 | Mid-pregnancy circulating cytokine levels, histologic chorioamnionitis and spontaneous preterm birth |
Q33993285 | Noninvasive and quantitative assessment of in vivo fetomaternal interface angiogenesis using RGD-based fluorescence. |
Q38729072 | Notch2 and Notch3 suppress the proliferation and mediate invasion of trophoblast cell lines. |
Q47267349 | Oxidative Stress, Antioxidant Status and Neurodevelopmental Outcome in Neonates Born to Pre-eclamptic Mothers |
Q38017497 | Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome |
Q24649934 | Pathophysiology of placentation abnormalities in pregnancy-induced hypertension |
Q36225249 | Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate |
Q38016970 | Preeclampsia, placenta, oxidative stress, and PMCA. |
Q34627421 | Reduced uterine perfusion pressure induces hypertension in the pregnant mouse |
Q36875755 | Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia |
Q34501647 | The effect of interleukin-17 on the proliferation and invasion of JEG-3 human choriocarcinoma cells |
Q33834419 | The role of inflammation in the pathology of preeclampsia |
Q38316934 | Three mechanisms in the pathogenesis of pre-eclampsia suggested by over-represented transcription factor-binding sites detected with comparative promoter analysis. |
Q42199197 | Up-regulated expression of Tim-3/Gal-9 at maternal-fetal interface in pregnant woman with recurrent spontaneous abortion |
Q37734745 | Upregulated unique long 16 binding protein 1 detected in preeclamptic placenta affects human extravillous trophoblast cell line (HTR-8/SVneo) invasion by modulating the function of uterine natural killer cells |
Q28070253 | Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia |
Search more.